ASBP Filings

SEC Filings
25 filings found
Filing DateFormAccession #View
2026-08-198-K0001493152-26-039135SEC →
2026-08-14SCHEDULE 13G/A0000919574-26-005317SEC →
2026-08-1310-Q0001493152-26-037819SEC →
2026-08-108-K0001493152-26-036777SEC →
2026-08-10SCHEDULE 13G0001213900-26-087424SEC →
2026-08-06SCHEDULE 13G/A0001493152-26-036445SEC →
2026-07-208-K0001493152-26-033942SEC →
2026-07-02SCHEDULE 13G0002142929-26-000001SEC →
2026-06-228-K0001493152-26-029599SEC →
2026-06-128-K0001493152-26-028518SEC →
2026-06-128-K0001493152-26-028386SEC →
2026-05-1510-Q0001493152-26-023802SEC →
2026-05-15SCHEDULE 13G0000919574-26-003204SEC →
2026-05-148-K0001493152-26-023069SEC →
2026-05-13SCHEDULE 13G/A0001213900-26-055622SEC →
2026-05-12DEFR14A0001493152-26-022511SEC →
2026-05-08DEF 14A0001493152-26-022026SEC →
2026-04-27PRE 14A0001493152-26-019171SEC →
2026-04-208-K0001493152-26-018018SEC →
2026-04-178-K/A0001493152-26-017145SEC →
2026-04-168-K0001493152-26-017115SEC →
2026-04-168-K0001493152-26-017054SEC →
2026-04-168-K0001493152-26-016979SEC →
2026-04-158-K0001493152-26-016683SEC →
2026-04-14EFFECT9999999995-26-001178SEC →
10-K Annual Report
Loading section...
Risk Factors
Loading risk factors...
Aspire Biopharma (ASBP) — Filings